Influence of PMEA-coated bypass circuits on perioperative inflammatory response

Annals of Thoracic Surgery

Volumn 75, Issue 3, 2003, Pages 913-917

  Ninomiya, Mikio ^a,b   Miyaji, Kagami ^a   Takamoto, Shinichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; COMPLEMENT COMPONENT C3A; ELASTASE; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BIOCOMPATIBILITY; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEMENT ACTIVATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG EFFECT; FEMALE; HEART VALVE SURGERY; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; MALE; MATERIAL COATING; PERIOPERATIVE PERIOD; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE COUNT; THROMBOCYTE PRESERVATION; TREATMENT OUTCOME;

AGED; CARDIOPULMONARY BYPASS; COATED MATERIALS, BIOCOMPATIBLE; COMPLEMENT C3A; CORONARY ARTERY BYPASS; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INTERLEUKIN-6; LEUKOCYTE ELASTASE; MALE; MIDDLE AGED; PLATELET COUNT; POSTOPERATIVE COMPLICATIONS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0037335069     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(02)04407-7     Document Type: Article

References (12)

1. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993;55:552-9.
2. Courtney JM, Matata BM, Yin HQ, Esposito A, Mahiout A. The influence of biomaterials on inflammatory responses to cardiopulmonary bypass. Perfusion 1996;11:220-8.
3. Edmunds LH Jr. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1998;66(Suppl):S12-6.
4. Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 2002;21:232-44.
5. Baykut D, Bernet F, Wehrle J, Weichelt K, Schwartz P, Zerkowski HR. New surface biopolymers for oxygenators: an in vitro hemocompatibility test of poly(2-methoxyethylacrylate). Eur J Med Res 2001;6:297-305.
6. Onishi M, Shimura K, Seita Y, Yamashita S. Design of a new plasma separation membrane by graft copolymerization. Radiat Phys Chem 1995;46:219-24.
7. Tanaka M, Motomura T, Kawada M, et al. Blood compatible aspects of poly(2-methoxyethylacrylate) (PMEA): relationship between protein adsorption and platelet adhesion on PMEA surface. Biomaterials 2000;21:1471-81.
8. Saito N, Motoyama S, Sawamoto J. Effects of new polymercoated extracorporeal circuits on biocompatibility during cardiopulmonary bypass. Artif Organs 2000;24:547-54.
9. Suhara H, Sawa Y, Nishimura M, et al. Efficacy of a new coating material, PMEA, for cardiopulmonary bypass circuits in a porcine model. Ann Thorac Surg 2001;71:1603-8.
10. Gu YJ, Oeveren WV, Akkerman C, et al. Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993;55:917-22.
11. Videm V, Svennevig JL, Fosse E, et al. Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations. J Thorac Cardiovasc Surg 1992; 103:806-13.
12. Moen O, Hogasen K, Fosse E, et al. Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg 1997;63:105-11.